MICROBIOME THERAPEUTIC INNOVATION GROUP
Data sourced from IRS 990 public filings
MICROBIOME THERAPEUTIC INNOVATION GROUP Homewebadmin2025-11-05T09:54:22-05:00 MissionThrough a collective voice, the MTIG membership works together to enhance the regulatory, investment, and commercial environment to accelerate microbiome therapeutic product development and expand availability of life-changing and life-saving FDA approved microbiome therapies to patients. . Read MoreAbout the MicrobiomeThe human microbiome is one of the new frontiers of medicine that has the potential to benefit patients suffering from numerous diseases afflicting millions of patients and consuming billions of dollars of healthcare resources. . . Read MoreInquire about MembershipAll pharmaceutical and biotechnology companies pursuing regulatory approvals for microbiome therapeutics and microbiome-based products are eligible for consideration of membership in MTIG. . . . Read MoreMember Companies
Annual Revenue
$404,063
Known Funders
0
Grants Received
0
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $404,063 | $478,029 | $42,287 |
| 2023 | $558,236 | $501,146 | $116,253 |
| 2022 | $394,988 | $543,529 | $59,163 |
| 2021 | $487,464 | $437,474 | $207,704 |
| 2020 | $262,500 | $321,491 | $157,714 |
| 2019 | $420,001 | $216,957 | $216,705 |
Top Funders
No funder data available yet for this nonprofit.
Key Personnel
From 2024 IRS 990 filing
TOM FAGLEY
TREASURER
STEPHEN CONAFAY
SECRETARY
JOHAN VAN HYLCKAMA VLIEG
VICE CHAIRMAN
NIKOLE KIMES
CHAIRMAN
TOM FAGLEY
TREASURER
STEPHEN CONAFAY
SECRETARY
JOHAN VAN HYLCKAMA VLIEG
VICE CHAIRMAN
Frequently Asked Questions
Other Nonprofits in District of Columbia
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.